About Allergan - Anda Distribution Business
Allergan (NYSE: AGN), fka Actavis and before that Watson Pharmaceuticals, is a global pharmaceutical company focused on developing, manufacturing, and commercializing innovative branded pharmaceuticals, high-quality generic, and over-the-counter medicines and biologic products for patients around the world. Allergan markets a portfolio of products that provide treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women's health, urology, cardiovascular, and anti-infective therapeutic categories. Actavis is also engaged in research and development. Watson Pharmaceuticals took on the name Actavis after its 2012 acquisition of the Swiss drug maker of the same name; Actavis later took on the name Allergan after its 2015 acquisition of the American health care company of the same name.
Missing: Allergan - Anda Distribution Business's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Allergan - Anda Distribution Business's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Allergan - Anda Distribution Business Frequently Asked Questions (FAQ)
Where is Allergan - Anda Distribution Business's headquarters?
Allergan - Anda Distribution Business's headquarters is located at Clonshaugh Business and Technology Park, Dublin.
What is Allergan - Anda Distribution Business's latest funding round?
Allergan - Anda Distribution Business's latest funding round is Acquired Unit.
Who are the investors of Allergan - Anda Distribution Business?
Investors of Allergan - Anda Distribution Business include Teva Pharmaceuticals.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.